Mutant p53 proteins allow the accumulation of various genetic alterations due to DNA damage and can also gain oncogenic properties by promoting cell migration, invasion, and metabolic reprogramming, further contributing to the malignancy of CRC [91,92]. The gene discussed is TP53; the disease is colorectal carcinoma.